ARTICLE | Clinical News
biocrea preclinical data
September 19, 2011 7:00 AM UTC
In rats, BCR909 significantly reversed impaired novel object recognition that resulted from either disruption of cholinergic or glutamatergic neurotransmission. Furthermore, the phosphodiesterase-2 (...